• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by American Shared Hospital Services (Amendment)

    4/3/24 12:14:23 PM ET
    $AMS
    Medical Specialities
    Health Care
    Get the next $AMS alert in real time by email
    SC 13D/A 1 rcs20240402_sc13da.htm SCHEDULE 13D/A rcs20240402_sc13da.htm

     



     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     


     

    SCHEDULE 13D/A

     

    Under The Securities Exchange Act Of 1934

    (Amendment No. 6)*

     


     

    American Shared Hospital Services

    (Name of Issuer)

     

    Common Stock, no par value

    (Title of Class of Securities)

     

    029595-10-5

    (CUSIP Number)

     

    Raymond C. Stachowiak

    American Shared Hospital Services

    601 Montgomery Street

    Suite 1112

    San Francisco, California 94111

    (415) 788-5300

     

    with a copy to:

     

    Joseph R. DeHondt

    Dykema Gossett PLLC

    39577 Woodward Avenue
    Suite 300
    Bloomfield Hills, MI 48304

    (248) 203-0700

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

     

    April 1, 2024

    (Date of Event Which Requires Filing of This Statement)

     


     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

     

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     



     

     

     

     

    CUSIP NO. 029595-10-5

    1

    Name Of Reporting Person

     

    Raymond C. Stachowiak, individually and as the (i) owner-president of RCS Investments, Inc., and (ii) owner-manager of Stachowiak Equity Fund, LLC

    2

    Check The Appropriate Box If A Member Of A Group (See Instructions):

    (a)          ☐

    (b)          ☐

    3

    SEC Use Only

     

     

    4

    Source Of Funds (See Instructions)

     

    PF, OO

    5

    Check If Disclosure Of Legal Proceedings Is Required Pursuant To Items 2(d) Or 2(e)

     

    Not Applicable.

    6

    Citizenship Or Place Of Organization

     

    United States

    Number of

    shares

    beneficially

    owned by

    each

    reporting

    person with:

    7

    Sole Voting Power

     

    470,678 (1)

    8

    Shared Voting Power

     

    919,059 (2) (3)

    9

    Sole Dispositive Power

     

    470,678 (1)

    10

    Shared Dispositive Power

     

    919,059 (2) (3)

    11

    Aggregate Amount Beneficially Owned By Each Reporting Person

     

    1,389,737 (1)

    12

    Check If The Aggregate Amount In Row (11) Excludes Certain Shares (See Instructions): ☐

     

     

    13

    Percent Of Class Represented By Amount In Row 11

     

    21.9% (4)

    14

    Type Of Reporting Person

     

    IN, OO

     

    (1)

    Includes 6,000 shares of common stock, no par value (the “Common Stock”), of American Shared Hospital Services (the “Issuer”) that will be issuable to Mr. Stachowiak within 60 days of April 3, 2024, the filing date of this Schedule 13D/A (the “Filing Date”), upon his exercise of certain stock options previously granted to him.

     

    (2)

    Includes 158,500 shares of Common Stock owned by RCS Investments, Inc. (“RCS”), of which Mr. Stachowiak is the president. RCS is wholly owned by the Raymond C Stachowiak Revocable Trust dated November 19, 1998 (the “Stachowiak Trust”), of which Mr. Stachowiak is the sole trustee and, in such capacity, may direct the voting and investment of the securities held by RCS. In his capacity as owner-president of RCS, Mr. Stachowiak may be deemed to have or share beneficial ownership of the shares of Common Stock held of record by RCS.

     

    (3)

    Includes 760,559 shares of Common Stock owned by Stachowiak Equity Fund, LLC (“Stachowiak Equity”), of which Mr. Stachowiak is the manager. Stachowiak Equity is owned 60% by the Stachowiak Trust, of which Mr. Stachowiak is the sole trustee, and 20% by each of two trusts established for Mr. Stachowiak’s children, of which Mr. Stachowiak’s spouse is the sole trustee. In his capacity as owner-manager of Stachowiak Equity, Mr. Stachowiak may be deemed to have or share beneficial ownership of the shares of Common Stock held of record by Stachowiak Equity.

     

    (4)

    This percentage was calculated in accordance with the U.S. Securities and Exchange Commission (the “SEC”) rules for calculating percentages of beneficial ownership, based on the Issuer having an aggregate of 6,330,000 shares of Common Stock issued and outstanding as of March 22, 2024, as reported by the Issuer in its Annual Report on Form 10-K filed with the SEC on April 1, 2024 (the “2024 Annual Report”).

     

     

     

     

    CUSIP NO. 029595-10-5

    1

    Name Of Reporting Person

     

    RCS Investments, Inc.

    2

    Check The Appropriate Box If A Member Of A Group (See Instructions):

    (a)          ☐

    (b)          ☐

    3

    SEC Use Only

     

     

    4

    Source Of Funds (See Instructions):

     

    WC, OO

    5

    Check If Disclosure Of Legal Proceedings Is Required Pursuant To Items 2(d) Or 2(e)

     

    Not Applicable.

    6

    Citizenship Or Place Of Organization

     

    United States (Illinois)

    Number of

    shares

    beneficially

    owned by

    each

    reporting

    person with:

    7

    Sole Voting Power

     

    0

    8

    Shared Voting Power

     

    158,500

    9

    Sole Dispositive Power

     

    0

    10

    Shared Dispositive Power

     

    158,500

    11

    Aggregate Amount Beneficially Owned By Each Reporting Person

     

    158,500

    12

    Check If The Aggregate Amount In Row (11) Excludes Certain Shares (See Instructions): ☐

     

     

    13

    Percent Of Class Represented By Amount In Row 11

     

    2.5% (1)

    14

    Type Of Reporting Person

     

    CO

     

    (1)

    This percentage is based on the Issuer having an aggregate of 6,330,000 shares of Common Stock issued and outstanding as of March 22, 2024, as reported in the Issuer’s 2024 Annual Report.

     

     

     

     

    CUSIP NO. 029595-10-5

    1

    Name Of Reporting Person

     

    Stachowiak Equity Fund, LLC

    2

    Check The Appropriate Box If A Member Of A Group (See Instructions):

    (a)          ☐

    (b)          ☐

    3

    SEC Use Only

     

     

    4

    Source Of Funds (See Instructions):

     

    WC, OO

    5

    Check If Disclosure Of Legal Proceedings Is Required Pursuant To Items 2(d) Or 2(e)

     

    Not Applicable.

    6

    Citizenship Or Place Of Organization

     

    United States (Illinois)

    Number of

    shares

    beneficially

    owned by

    each

    reporting

    person with:

    7

    Sole Voting Power

     

    0

    8

    Shared Voting Power

     

    760,559

    9

    Sole Dispositive Power

     

    0

    10

    Shared Dispositive Power

     

    760,559

    11

    Aggregate Amount Beneficially Owned By Each Reporting Person

     

    760,559

    12

    Check If The Aggregate Amount In Row (11) Excludes Certain Shares (See Instructions): ☐

     

     

    13

    Percent Of Class Represented By Amount In Row 11

     

    12.0% (1)

    14

    Type Of Reporting Person

     

    OO

     

    (1)

    This percentage is based on the Issuer having an aggregate of 6,330,000 shares of Common Stock issued and outstanding as of March 22, 2024, as reported in the Issuer’s 2024 Annual Report.

     

     

     

     

    EXPLANATORY NOTE

     

    This Schedule 13D/A constitutes Amendment No. 6 (this “Schedule 13D/A No. 6”) to the original Schedule 13D dated June 17, 2014, as amended on October 28, 2014, February 16, 2016, May 21, 2019, May 4, 2020, and May 3, 2023 (as amended, the “Original Schedule 13D”), filed with the U.S. Securities and Exchange Commission (the “SEC”) by Mr. Raymond C. Stachowiak, a member and the Executive Chairman of the board of directors (the “Board”) of American Shared Hospital Services, a California corporation (the “Issuer”). The Original Schedule 13D reported Mr. Stachowiak’s ownership of the Issuer’s common stock, no par value (the “Common Stock”), both directly and indirectly through RCS Investments, Inc., an Illinois corporation (“RCS”), of which Mr. Stachowiak is the owner-president, and Stachowiak Equity Fund, LLC, an Illinois limited liability company (“Stachowiak Equity”; together with RCS and Mr. Stachowiak, the “Reporting Persons,” and each, a “Reporting Person”), of which Mr. Stachowiak is the owner-manager.

     

    This Schedule 13D/A No. 6 is being filed to report the shares of Common Stock (the “Common Shares”) that Mr. Stachowiak has acquired since filing Amendment No. 5 to the Original Schedule 13D with the SEC on May 3, 2023 (the “Schedule 13D/A No. 5”). This Schedule 13D/A No. 6 also updates the percentages of beneficial ownership reported for RCS and Stachowiak Equity, which immaterially decreased due to an increase in the Issuer’s total number of issued and outstanding Common Shares since the Schedule 13D/A No. 5 was filed. Only those items that are hereby reported are amended; all other items reported in the Original Schedule 13D remain unchanged. Information given in response to each item shall be deemed incorporated by reference in all other items, as applicable. Capitalized terms not defined in this Schedule 13D/A No. 6 have the meanings ascribed to them in the Original Schedule 13D.

     

    Item 3.

    Source and Amount of Funds or Other Consideration.

     

    This Schedule 13D/A No. 6 supplements Item 3 of the Original Schedule 13D by adding the following:

     

    Source of Mr. Stachowiak’s Shares.  The aggregate number of Common Shares reported as beneficially owned (the “Total Beneficial Ownership Amount”) by Mr. Stachowiak in this Schedule 13 D/A No. 6 include the Common Shares acquired in the transactions described below that occurred since Mr. Stachowiak’s reporting of beneficial ownership in the Schedule 13D/A No. 5.

     

     

    ●

    On March 28, 2023, Mr. Stachowiak was granted an award of 120,000 restricted stock units (“RSUs”), which vested in equal quarterly installments on April 1, 2023, July 1, 2023, October 1, 2023, and January 1, 2024. The Total Beneficial Ownership Amount reported for Mr. Stachowiak in this Schedule 13D/A No. 6 includes the 60,000 Common Shares underlying the 60,000 RSUs granted to Mr. Stachowiak that vested on October 1, 2023 and January 1, 2024, which were excluded from Mr. Stachowiak’s Total Beneficial Ownership Amount in the Schedule 13D/A No. 5 because the RSUs did not vest within 60 days of the filing date of the Schedule 13D/A No. 5.

     

     

    ●

    On March 22, 2024, Mr. Stachowiak was granted an award of 120,000 RSUs (the “2024 RSUs”), which vested or will vest in equal quarterly installments on April 1, 2024, July 1, 2024, October 1, 2024, and January 1, 2025. For purposes of this Schedule 13D/A No. 6, only 30,000 Common Shares underlying 30,000 of the 2024 RSUs are included in Mr. Stachowiak’s Total Beneficial Ownership Amount. The remaining 90,000 of the 2024 RSUs and underlying Common Shares are excluded from Mr. Stachowiak’s Total Beneficial Ownership Amount because they will not vest within 60 days of April 3, 2024, the filing date of this Schedule 13D/A No. 6 (the “Filing Date”).

     

    Item 4.

    Purpose of Transaction.

     

    This Schedule 13D/A No. 6 amends and restates Item 4 of the Original Schedule 13D as follows:

     

    The information reported in Item 3 of this Schedule 13D/A No. 6 is incorporated by reference into this Item 4. The Common Shares reported as beneficially owned by the Reporting Persons will be held for investment purposes.

     

     

     

     

    Before Mr. Stachowiak became an officer and director of the Issuer, the securities acquired by Mr. Stachowiak were primarily acquired through purchases using his personal funds. After Mr. Stachowiak became an officer of the Issuer, Mr. Stachowiak acquired Common Shares from the Issuer as partial compensation for his service as an officer, including for his former officer roles as Interim President and Chief Executive Officer and for his current officer role as Executive Chairman of the Issuer.

     

    Mr. Stachowiak is a director and the Executive Chairman of the Issuer, the owner-president of RCS, and the owner-manager of Stachowiak Equity. Except as set forth herein and to the extent that Mr. Stachowiak may have influence over the corporate activities of the Issuer, including activities that may relate to the items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D, the Reporting Persons do not have any present plan or proposal that relate to or would result in any of the matters set forth in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

     

    The Reporting Persons reserve the right to increase or decrease their position in the Issuer through, among other things, the purchase or sale of securities of the Issuer on the open market or in private transactions or otherwise on such terms and at such times as the Reporting Persons may deem advisable. The Reporting Persons reserve the right to change their intention with respect to any and all matters referred to in this Item 4.

     

    Item 5.

    Interest in Securities of the Issuer.

     

    This Schedule 13D/A No. 6 amends and restates Item 5 of the Original Schedule 13D as follows:

     

    The table below reports the aggregate number of Common Shares beneficially owned by each Reporting Person, the total issued and outstanding Common Shares ( the “Total I&O Amount”) used to calculate each Reporting Person’s percentage of beneficial ownership in accordance with the SEC rules for calculating percentages of beneficial ownership, and each Reporting Person’s percentage of beneficial ownership as of the Filing Date of this Schedule 13D/A No. 5.

     

    Reporting Person

     

    Aggregate Number of Common Shares Beneficially Owned

     

    Total I&O Amount of Common Shares

     

    Beneficial Ownership Percentage

    Mr. Stachowiak(1)

     

    1,389,737

     

    6,336,000(2)

     

    21.9%

    RCS

     

    158,500

     

    6,330,000(3)

     

    2.5%

    Stachowiak Equity

     

    760,559

     

    6,330,000(3)

     

    12.0%

     


     

    (1)

    Mr. Stachowiak’s beneficial ownership includes his direct beneficial holdings as well as his indirect beneficial holdings as the (i) owner-president of RCS, and (ii) owner-manager of Stachowiak Equity.

     

     

    (2)

    Mr. Stachowiak’s Total I&O Amount consists of the (i) 6,330,000 Common Shares reported by the Issuer as being issued and outstanding as of March 22, 2024, as reported by the Issuer in its 2024 Annual Report, and (ii) 6,000 Common Shares that Mr. Stachowiak has the right to acquire within 60 days of April 3, 2024 upon his exercise of certain stock options previously granted to him.

     

     

    (3)

    The Reporting Person’s Total I&O Amount is equal to the 6,330,000 Common Shares reported by the Issuer as being issued and outstanding in its 2024 Annual Report.

     

     

     

     

    (b)         With respect to each Reporting Person as of the Filing Date, the table below reports the number of Common Shares as to which there is sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition. Each Reporting Person expressly disclaims beneficial ownership of all of the Common Shares reported in this Schedule 13D/A No. 6 except to the extent of such Reporting Person’s pecuniary interest therein, and the filing of this Schedule 13D/A No. 6 shall not be construed as an admission that any such Reporting Person is, for purposes of Sections 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended, the beneficial owner of any securities covered by this Schedule 13D/A No. 6.

     

    Reporting Person

     

    Sole Voting Power

     

    Shared Voting Power

     

    Sole Dispositive Power

     

    Shared Dispositive Power

     

    Total Beneficially Owned

    Mr. Stachowiak

     

    470,678

     

    919,059

    (1)

    470,678

     

    919,059

    (1)

    1,389,737

    RCS

     

    0

     

    158,500

     

    0

     

    158,500

     

    158,500

    Stachowiak Equity

     

    0

     

    760,559

     

    0

     

    760,559

     

    760,559

     


     

    (1)

    Includes: (i) 158,500 Common Shares held of record by RCS, which Mr. Stachowiak may be deemed to have or share voting and investment power over in his capacity as president of RCS and as the sole trustee of the Raymond C Stachowiak Revocable Trust dated November 19, 1998 (the “Stachowiak Trust”), which is the sole owner of RCS; and (ii) 760,559 Common Shares held of record by Stachowiak Equity, which is owned 60% by the Stachowiak Trust, of which Mr. Stachowiak is the sole trustee, and 20% by each of two trusts established for Mr. Stachowiak’s children (the “Stachowiak Children Trusts”), of which Mr. Stachowiak’s spouse is the sole trustee. The principal address of the Stachowiak Children Trusts is 7N120 Weybridge Drive, St. Charles, Illinois 60175. The principal business of the Stachowiak Children Trusts is to make and hold investments in securities and other assets. No other information required by Item 2 with respect to the Stachowiak Children Trusts is applicable.

     

    (c)         Except as described in Item 3, Item 6, or elsewhere in this Schedule 13D/A No. 6, no transactions in the Common Shares reported in this Schedule 13D/A No. 6 were effected by the Reporting Persons during the past 60 days.

     

    (d)         Except as set forth herein, to the knowledge of the Reporting Persons, no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any Common Shares beneficially owned by the Reporting Persons.

     

    (e)         Not applicable.

     

    Item 6.

    Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.

     

    Except as otherwise set forth in this Schedule 13D/A No. 6, there are no contracts, arrangements, understandings, or similar relationships existing with respect to the securities of the Issuer between the Issuer and the Reporting Persons.

     

    Item 7.

    Material to be Filed as Exhibits.

     

    ExhibitNo.

    Description

     

    99.1

    Joint Filing Agreement by and among the Reporting Persons.

     

     

     

     

    SIGNATURES

     

    After reasonable inquiry and to the best of my knowledge and belief, the Reporting Persons certify that the information set forth in this statement is true, complete, and correct.

     

    Date: April 3, 2024

     

     

     

    /s/ Raymond C. Stachowiak

     

     

    Raymond C. Stachowiak, individually

     

     

     

     

     

           
      RCS INVESTMENTS, INC.  
           
      By: /s/ Raymond C. Stachowiak  
       

    Raymond C. Stachowiak

    President

     
           
           
      STACHOWIAK EQUITY FUND, LLC  
           
      By: /s/ Raymond C. Stachowiak  
       

    Raymond C. Stachowiak

    Manager

     

     

     
    Get the next $AMS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AMS

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $AMS
    Leadership Updates

    Live Leadership Updates

    See more
    • American Shared Hospital Services Announces Key Management Appointments

      Hires Gary Delanois, Seasoned Radiation Oncology Services Executive, as Chief Operating Officer Promotes Ranjit Pradhan to Senior Vice President of Sales and Marketing SAN FRANCISCO, Oct. 18, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced the appointment of Gary Delanois as Executive Vice President and Chief Operating Officer. Mr. Delanois brings many years of industry expertise in the management of radiation oncology services. Additionally, the Company announced the promotion of Ranj

      10/18/24 2:58:45 PM ET
      $AMS
      Medical Specialities
      Health Care
    • American Shared Hospital Services Strengthens Senior Management Structure

      SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment and services, today announces changes to strengthen its senior management structure. AMS' current Executive Chairman, Ray Stachowiak, will take on the role of Executive Chairman and Chief Executive Officer, and the Company's President, Craig Tagawa, will become President and Chief Operating Officer, effective immediately. Bob Hiatt will continue to serve as the Company's Chief Financial Officer. Ernie Bates will continue in the role of Vice President of I

      4/18/24 8:00:00 AM ET
      $AMS
      Medical Specialities
      Health Care
    • American Shared Hospital Services Strengthens Management Team with Appointment of Peter Gaccione as Chief Operating Officer

      Gaccione is a Well Known & Respected Radiation Oncology Business Development, Sales & Management Executive SAN FRANCISCO, CA, Sept. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy equipment, facilities, and services, today announced the appointment of Peter Gaccione as Chief Operating Officer (COO), effective September 7th, 2022. Mr. Gaccione assumes the COO position from Craig Tagawa who remains the Company's President and Chief Financial Officer. Mr. Gaccione has over 40 years of experience and leadership in the gl

      9/1/22 4:05:00 PM ET
      $AMS
      Medical Specialities
      Health Care

    $AMS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by American Shared Hospital Services

      SC 13D - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Subject)

      11/20/24 4:59:03 PM ET
      $AMS
      Medical Specialities
      Health Care
    • SEC Form SC 13D/A filed by American Shared Hospital Services (Amendment)

      SC 13D/A - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Subject)

      4/3/24 12:14:23 PM ET
      $AMS
      Medical Specialities
      Health Care
    • SEC Form SC 13D/A filed by American Shared Hospital Services (Amendment)

      SC 13D/A - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Subject)

      12/18/23 4:44:44 PM ET
      $AMS
      Medical Specialities
      Health Care

    $AMS
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $AMS
    Financials

    Live finance-specific insights

    See more
    • American Shared Hospital Services Announces Annual Shareholder Meeting to be Held on Thursday, June 26, 2025

      SAN FRANCISCO, April 11, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing or direct patient care services segments, today announced that its Annual Meeting of Shareholders will be held on Thursday, June 26, 2025, at 9:00 a.m. CT. The Annual Meeting will be an in-person meeting. For those who wish to attend, the meeting will be held at 3041 Woodcreek Drive, #200, Downers Grove, IL 60515. The Board of Directors fixed the close of business on April 28, 2025, as the record date for determination of shareholders entitled to

      4/11/25 7:00:00 AM ET
      $AMS
      Medical Specialities
      Health Care
    • American Shared Hospital Services to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub

      SAN FRANCISCO, April 09, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing or direct patient care services segments, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 12:00 PM ET. Ray Stachowiak, Executive Chairman, and Gary Delanois, Chief Executive Officer of American Shared Hospital Services, will host the presentation and answer questions at the conclusion. To access the live presentation, please use the following

      4/9/25 7:00:00 AM ET
      $AMS
      Medical Specialities
      Health Care
    • American Shared Hospital Services Reports Fourth Quarter and Strong Full Year 2024 Financial Results

      Appoints Gary Delanois as Chief Executive Officer Conference Call Scheduled for 1:00 PM ET Today SAN FRANCISCO, April 04, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing or direct patient care services segments, today announced financial results for the fourth quarter and full year ended December 31, 2024. Key Financial Highlights FY 2024 Revenue Increased 32.9% Year over Year Driven by Strategic Expansion and Operational StrengthFY 2024 Direct Patient Services Revenue Increased 253.4% Year over YearNet Income Attr

      4/4/25 7:00:00 AM ET
      $AMS
      Medical Specialities
      Health Care
    • American Shared Hospital Services Reports Fourth Quarter and Strong Full Year 2024 Financial Results

      Appoints Gary Delanois as Chief Executive Officer Conference Call Scheduled for 1:00 PM ET Today SAN FRANCISCO, April 04, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services through its leasing or direct patient care services segments, today announced financial results for the fourth quarter and full year ended December 31, 2024. Key Financial Highlights FY 2024 Revenue Increased 32.9% Year over Year Driven by Strategic Expansion and Operational StrengthFY 2024 Direct Patient Services Revenue Increased 253.4% Year over YearNet Income Attr

      4/4/25 7:00:00 AM ET
      $AMS
      Medical Specialities
      Health Care
    • American Shared Hospital Services Announces Fourth Quarter and Full Year 2024 Earnings Conference Call

      SAN FRANCISCO, March 31, 2025 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of stereotactic radiosurgery and advanced radiation therapy cancer treatment services, today announced that the Company will hold a conference call to discuss its fourth quarter and full year 2024 financial results on April 4th at 1:00 pm ET. The fourth quarter and full-year 2024 financial results press release will be issued before the market opens on April 4th. Teleconference and Webcast Information To participate, domestic callers may dial 1-844-413-3972 and international callers may dial 1-412-317-5776 at least 10 minutes prior to the start of the call a

      3/31/25 4:01:00 PM ET
      $AMS
      Medical Specialities
      Health Care
    • American Shared Hospital Services Reports Third Quarter 2024 Financial Results

      - Revenue increases 36.3% period over period - Conference Call on November 13th at 1:00 pm ET SAN FRANCISCO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- American Shared Hospital Services (NYSE:AMS) (the "Company"), a leading provider of turnkey technology solutions for stereotactic radiosurgery and advanced radiation therapy cancer treatment systems and services, today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 and Recent Highlights Total revenue in the third quarter was $6,999,000, an increase of 36.3% from the comparable period in 2023 bolstered by the completion of our acquisition in May 2024 (the "RI Acquisition") of 60% of the equity inte

      11/13/24 7:00:00 AM ET
      $AMS
      Medical Specialities
      Health Care

    $AMS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President Tagawa Craig Kenji was granted 5,613 shares, increasing direct ownership by 19% to 35,501 units (SEC Form 4)

      4 - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Issuer)

      5/2/25 11:49:55 AM ET
      $AMS
      Medical Specialities
      Health Care
    • Chief Financial Officer Frech Raymond Scott was granted 50,000 shares (SEC Form 4)

      4 - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Issuer)

      12/23/24 8:19:24 PM ET
      $AMS
      Medical Specialities
      Health Care
    • SEC Form 3 filed by new insider Frech Raymond Scott

      3 - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Issuer)

      12/23/24 8:18:51 PM ET
      $AMS
      Medical Specialities
      Health Care

    $AMS
    SEC Filings

    See more
    • SEC Form DEFA14A filed by American Shared Hospital Services

      DEFA14A - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Filer)

      4/30/25 3:24:24 PM ET
      $AMS
      Medical Specialities
      Health Care
    • SEC Form DEF 14A filed by American Shared Hospital Services

      DEF 14A - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Filer)

      4/30/25 3:15:03 PM ET
      $AMS
      Medical Specialities
      Health Care
    • SEC Form 10-K filed by American Shared Hospital Services

      10-K - AMERICAN SHARED HOSPITAL SERVICES (0000744825) (Filer)

      4/4/25 5:19:54 PM ET
      $AMS
      Medical Specialities
      Health Care